mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |